← Back to Search

Subjects with history of arrhythmia for Cardiac Arrhythmias

N/A
Waitlist Available
Led By William Powers, MD
Research Sponsored by The University of Texas Medical Branch, Galveston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 min, assessed during the duration of acceleration exposure
Awards & highlights

Study Summary

This trial will test how people with diabetes or heart arrhythmias respond to G-forces, compared to people without these conditions.

Eligible Conditions
  • Cardiac Arrhythmias
  • Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 min, assessed during the duration of acceleration exposure
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 min, assessed during the duration of acceleration exposure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood Glucose
Diastolic Blood Pressure - after
Diastolic Blood Pressure - before
+6 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Subjects with history of arrhythmiaExperimental Treatment1 Intervention
Individuals with history of cardiac arrhythmia
Group II: Diabetic SubjectsExperimental Treatment1 Intervention
Individuals with history of diabetes mellitus
Group III: Control SubjectsExperimental Treatment1 Intervention
Individuals without history of either Diabetes or cardiac arrhythmia

Find a Location

Who is running the clinical trial?

Civil Aerospace Medical InstituteFED
3 Previous Clinical Trials
291 Total Patients Enrolled
The University of Texas Medical Branch, GalvestonLead Sponsor
241 Previous Clinical Trials
56,548 Total Patients Enrolled
William Powers, MDPrincipal InvestigatorUniversity of Texas Medical Branch at Galveston

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~14 spots leftby Apr 2025